The Live Ahmedabad
  • Home
  • Ahd City
  • Business
  • Entertainment
  • Education
  • Crime
  • Health
  • Politics
  • Sports
  • Featured

The Live Ahmedabad

  • Home
  • Ahd City
  • Business
  • Entertainment
  • Education
  • Crime
  • Health
  • Politics
  • Sports
  • Featured
Ahmedabad HealthGujaratNation

EUA request filed by the Bharat Biotech’s US partner Ocugen for paediatric use of Covaxin

by TLA November 6, 2021November 6, 2021
written by TLA November 6, 2021November 6, 2021
EUA request filed by the Bharat Biotech’s US partner Ocugen for paediatric use of Covaxin

Bharat Biotech’s partner for USA and Canada for Covid-19 vaccine Covaxin, Ocugen Inc., has filed an application with the US Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the vaccine for pediatric use.
The submission is based on results of a Phase 2/3 paediatric clinical trial conducted by Bharat Biotech in India with 526 children 2-18 years of age, which bridged immunogenicity data to a large, Phase 3 safety and efficacy clinical trial in nearly 25,800 adults in India, Ocugen said in a regulatory filing.
“Filing for Emergency Use Authorization in the US for paediatric use is a significant step toward our hope to make our vaccine candidate available here and help combat the Covid-19 pandemic,” Shankar Musunuri, Chairman of the Board, Chief Executive Officer and Co-Founder of Ocugen said.
Some research suggests that people are seeking more choices when selecting a vaccine, especially for their children. Having a new type of vaccine available will enable people to discuss with their child’s physician the best approach for them to lower their child’s risk of contracting Covid-19, he further said.

Business News

“The inactivated virus platform has been used for decades in vaccines for the paediatric population and, if authorized, we hope to offer another vaccine option to protect children as young as two years,” he added.
A Phase 2/3, open-label, multi-center study was conducted in India from May 2021 to July 2021 to evaluate the safety, reactogenicity and immunogenicity of the whole-virion inactivated Vaccine in healthy volunteers in the 2-18 age group.
Covaxin was evaluated in three age groups: 2-6 years, 6-12 years and 12-18 years. All participants received two doses of the vaccine 28 days apart, it said.
Covaxin was recently awarded Emergency Use Listing by the World Health Organization.

Bharat BiotechCovaxinFood and Drug AdministrationLatest health newslatest newsNational Newspaediatric clinical trial
0 comment
previous post
Five labourers died while cleaning wastewater tank in Gandhinagar
next post
Sooryavanshi earns Rs 26 Cr on day 1, Biggest Bollywood Opener of Covid Era

You may also like

New Financial Rules from June 1: EPFO, Aadhaar...

June 1, 2025

COVID-19 Cases Rise in India, Over 3,000 Active;...

June 1, 2025

Indian Tourist Attacked by Tiger in Thailand While...

May 31, 2025

Modi Government Launches ‘1600’ Number Series to Stop...

May 31, 2025

June 2025 Bank Holidays: State-Wise List and Total...

May 31, 2025

WhatsApp to Stop Working on Some Old Phones...

May 31, 2025

Facebook Sees Spike in Harmful Content as Meta...

May 31, 2025

India’s Active COVID-19 Cases Rise to 2,710; Kerala...

May 31, 2025

Karnataka Bans Hookah Bars, Raises Tobacco Buying Age...

May 31, 2025

Baba Vanga’s 2025 Predictions: These Zodiac Signs May...

May 30, 2025

Leave a Comment Cancel Reply

Save my name, email, and website in this browser for the next time I comment.

Business News

Recent Posts

  • Gujarat Vidhyasahayak Recruitment for Classes 1 to 5 Cancelled, New Process Coming Soon

    June 1, 2025
  • Khushboo Kankan Flaunts Glamorous Look in Green Bikini

    June 1, 2025
  • Ahmedabad Collects ₹834.8 Crore in Property Tax with Advance Rebate scheme

    June 1, 2025
  • Adani Ports taps its Largest Ever Domestic bond – 5,000 crore 15-year NCD

    June 1, 2025
  • New Financial Rules from June 1: EPFO, Aadhaar & More Updates

    June 1, 2025
November 2021
MTWTFSS
1234567
891011121314
15161718192021
22232425262728
2930 
« Oct Dec »
The Live Ahmedabad
Footer Logo
  • Home
  • Ahd City
  • Business
  • Entertainment
  • Education
  • Crime
  • Health
  • Politics
  • Sports
  • Featured
  • Privacy Policy
  • Disclaimer
  • Cookie Policy
  • Terms of use
  • Advertise with Us
  • Work With Us
  • Contact Us

© 2021 - The Live Ahmedabad. All Rights Reserved.